Bid for British firm, which makes asthma inhalers, has caused outrage among health campaigners
Tobacco company Philip Morris International (PMI) has sealed its controversial £1.1bn takeover of asthma inhaler maker Vectura, after more than half of the target company’s shareholders agreed to sell their stock.
PMI said it had either bought shares, or received acceptances of its offer, reaching just under 75% of the company, well ahead of the 50% it needed.
